CODX vs ULTA · rev $3.9M vs P/E 17, rev $11.30B
Co-Diagnostics, Inc. Common Stock (CODX) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported ULTA revenue for 2025-02-01 was $11.30B. Net income was $1.20B. Revenue was up 0.8% from 2024-02-03 to 2025-02-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
CODX currently screens at market cap $31.4M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the CODX and ULTA stock pages for the full models.
Not investment advice.